Angela P. Schulz

Hamburg, HH, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 122 publications

Translational lipidomics reveals BMP and its precursor LPG as biomarkers for CLN5 Batten disease.

Translational lipidomics reveals BMP and its precursor LPG as biomarkers for CLN5 Batten disease.

Journal: bioRxiv : the preprint server for biology

Published: March 27, 2026

Translational lipidomics reveals BMP and its precursor LPG as biomarkers for CLN5 Batten disease.

Translational lipidomics reveals BMP and its precursor LPG as biomarkers for CLN5 Batten disease.

Journal: bioRxiv : the preprint server for biology

Published: March 27, 2026

Expression of GPR34 in microglia remains stable in human Alzheimer's disease.

Expression of GPR34 in microglia remains stable in human Alzheimer's disease.

Journal: Acta neuropathologica

Published: February 08, 2026

Mapping Clinical Progression to Brain Atrophy in CLN2 Patients Under Cerliponase Alfa Treatment: A Prospective Neuroimaging Study.

Mapping Clinical Progression to Brain Atrophy in CLN2 Patients Under Cerliponase Alfa Treatment: A Prospective Neuroimaging Study.

Journal: Journal of inherited metabolic disease

Published: October 22, 2025

The nuclear export inhibitor selinexor improves kidney function in a rat model of focal segmental glomerulosclerosis.

The nuclear export inhibitor selinexor improves kidney function in a rat model of focal segmental glomerulosclerosis.

Journal: American journal of physiology. Renal physiology

Published: September 02, 2025

A timeline of symptom onset and disease progression in CLN3 disease.

A timeline of symptom onset and disease progression in CLN3 disease.

Journal: Orphanet journal of rare diseases

Published: August 29, 2025

SyMetrics: an integrated machine learning model for evaluating the pathogenicity of synonymous variants in the human genome.

SyMetrics: an integrated machine learning model for evaluating the pathogenicity of synonymous variants in the human genome.

Journal: NAR genomics and bioinformatics

Published: April 26, 2025

Recommendations for the diagnosis and management of cln3 disease (batten disease) using the Delphi consensus methodology.

Recommendations for the diagnosis and management of cln3 disease (batten disease) using the Delphi consensus methodology.

Journal: Orphanet journal of rare diseases

Published: April 22, 2025

Real-world clinical outcomes of patients with CLN2 disease treated with cerliponase alfa.

Real-world clinical outcomes of patients with CLN2 disease treated with cerliponase alfa.

Journal: Frontiers in neurology

Published: October 23, 2024

Succinate receptor 1 signaling mutually depends on subcellular localization and cellular metabolism.

Succinate receptor 1 signaling mutually depends on subcellular localization and cellular metabolism.

Journal: The FEBS journal

Published: August 21, 2024

OCT Biomarkers in Ocular CLN2 Disease in Patients Treated With Intraventricular Enzyme Replacement Therapy.

OCT Biomarkers in Ocular CLN2 Disease in Patients Treated With Intraventricular Enzyme Replacement Therapy.

Journal: Investigative ophthalmology & visual science

Published: July 30, 2024

Maximizing the Utility of Alzheimer's Disease Trial Data: Sharing of Baseline A4 and LEARN Data.

Maximizing the Utility of Alzheimer's Disease Trial Data: Sharing of Baseline A4 and LEARN Data.

Journal: The journal of prevention of Alzheimer's disease

Published: July 24, 2024

Showing 1-12 of 122

Last Updated: 09/26/2026